• Latest Posts

Merck and Sigma-Aldrich: Together to solve the toughest problems in life science

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

The Best Selling Biologic of All Time now chased by New Phase III Biosimilar

Sanofi-Genzyme: Still successful 5 years after the acquisition?

Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial


The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach

Red Blood Cells to Carry Drugs? A US Start-Up Inspired by French Biotech to Focus on Rare Metabolic Disease

Merck Pulls out of Plans to Commercialize Cancer Drug After it Fails in Two Phase III Trials

How Big can be Small in Biotech – #BIO-Europe 2015 Keynote

Ablynx richly rewarded for MSD’s Nanobody Proof in Immuno-Oncology

Rabbit Antibodies proven to be more specific than Mice in Immuno-oncology PD-L1 Research